267P Ultrasound-guided injection with or without rehabilitation exercise in breast cancer survivors with subacromial-deltoid bursitis: Long-term results of a pilot randomized clinical study

Breast cancer (BC) survivors frequently complain of functional limitation the shoulder following treatments. Despite physical and psychological implications, optimal management this disabling condition is still debated. Thus, aim study was to assess long-term effects a comprehensive rehabilitation program, including ultrasound (US) guided injection sub-acromial deltoid bursa (SAD) combined with protocol. In randomized controlled study, adult BC SAD bursitis were assessed for eligibility randomly assigned Group A B. Both groups received corticosteroid US into bursa, while only 5 sessions, 1 hour each. Outcomes at baseline, after one week (T1), three months (T2), six (T3). It Numerical Pain Rating Scale (NPRS), handgrip strength (HGS) test, European Organization Research Treatment Cancer Quality Life Questionnaire (EORTC QLQ-C30), Oxford Shoulder Score (OSS), Global Perceived Effect (GPE), safety. Thirty-seven women (n=19; mean age: 56.05 ± 10.30 years) B (n=18; 58.39 12.09 years). No adverse events reported. Statistically significant within-group differences found in both terms NPRS T1, T2, T3 (p <0.05). The between-group analysis showed no > 0.05) T1; however, T2 reported (2.16 1.39 vs 4.78 1.77; p <0.05), HGS (25.11 3.20 20.33 4.92; p<0.001), OSS (17.00 3.27 33.11 6.471; p<0.0001), EORTC QLQ-C30 (Functional, Symptom Health subscales, p<0.05). Furthermore, remained significantly lower compared (2.56 1.05 4.65 1.13; <0.05) T3. strategy exercise may be considered safe, feasible, effective patients.